Nurix Therapeutics, Inc. · NASDAQ:NRIX
Redmile Group, LLC's stake in Nurix Therapeutics, Inc. fell to 9.90% (Schedule 13G/A)
Event Apr 20, 2026 · Filed Apr 24, 2026
Redmile Group, LLC's stake in Nurix Therapeutics, Inc. fell to 9.90%, 10,696,314 shares, as a passive investor on Apr 20, 2026. Filed Apr 24, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 10,696,314
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Redmile Group, LLC | 9.90% | 10,696,314 |
| Jeremy C. Green | 9.90% | 10,696,314 |
| RedCo II Offshore SPV LLC | 5.60% | 5,967,424 |
| RedCo II Master Fund, L.P. | 0% | 0 |
Source
Related
- Nurix Therapeutics, Inc.
- Redmile Group, LLC
- Nurix Therapeutics, Inc. shareholders
- Schedule 13G/A · Redmile Group, LLC · Aug 14, 2026
- Form 4 · Hansen Gwenn · Oct 15, 2026
- Form 4 · Gregory Julia P · Oct 14, 2026
- Form 4 · Ring Christine · Oct 2, 2026
- Schedule 13G · Perceptive Advisors LLC · Sep 23, 2026
- Form 4 · Ring Christine · Sep 2, 2026